SH

Shivaji Hanumant Salunkhe

Active Director Director DIN 10807618
DIN 10807618 First appointment Oct 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Shivaji Hanumant Salunkhe

Data last updated:

Shivaji Hanumant Salunkhe is a Director at Medihype Pharma Private Limited (since 2024). The company operates in Paper.

DIN 10807618
Primary Designation Director
Industry Paper
First Appointment 14 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medihype Pharma Private Limited U21001PN2024PTC234953
Director14 Oct 20242024Active

Board colleagues of Shivaji Hanumant Salunkhe

NameDINCompanyDesignation
Akshay Rajendra Bansode10807617Medihype Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medihype Pharma Private Limited
Premium access

Shareholding and investment profile for Shivaji Hanumant Salunkhe

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shivaji Hanumant Salunkhe

Shivaji Hanumant Salunkhe currently holds 1 directorship: Medihype Pharma Private Limited (Director, since 14 Oct 2024).

Shivaji Hanumant Salunkhe was first appointed on 14 Oct 2024 as Director at Medihype Pharma Private Limited.

The current boards of Shivaji Hanumant Salunkhe's companies include Akshay Rajendra Bansode (Medihype Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available